Purdue Pharma's Fate: New Company, Sackler Payments

0:00It's April 28th. This is Canada News Today, powered by AI. Purdue Pharma, the makers of OxyContin, might get dissolved and reborn as a new company called NOAA Pharma by the end of this week. That's if a federal judge in New Jersey hands down a criminal sentence on Tuesday, wrapping up the final hurdle in a huge settlement for thousands of. Law suits tie to the opioid crisis. This stems from a 2020 deal where Purdue admitted to weak controls on keeping their painkillers off the black market, plus shady payments, too. Doctors through speaker programs and electronic records tweaks to push more prescriptions, the company faces $8.3 billion in fines and forfeitures, but the Fed settled for just $225 million as part of the bigger payout plan. Victims and families hit hard by opioids. Over 900,000 deaths since 1999 are split. More than 54,000 personal injury claimants voted yes on the deal, but a vocal few dozen

1:01protested outside court last week, demanding. Criminal charges for the Sackler family owners, not just cash. One mom who lost her son called money, no substitute for real justice. The judge delayed the hearing from video only to let folks speak in person, balancing voices on both sides. One survivor in recovery says, approving it, brings closure, ditching the anger that's poisoned to healing. If too they go smooth, Sackler's kick in up to $7 billion over 15 years to fight the crisis. Documents go public and their names. Could, vanish from museums. This caps a wave of over $50 billion in industry settlements, shifting focus to recovery over endless fights.